Company
Crinetics
Driving the Next Generation of Endocrinology Care
Also known as Crinetics Pharmaceuticals, Crinetics Pharmaceuticals, Inc.
- Business model
- B2B
- Headquarters
- San Diego, CA, United States
- Legal name
- Crinetics Pharmaceuticals, Inc.
- crinetics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Crinetics (CRNX) is a biopharmaceutical company developing oral small molecule therapeutics for endocrine diseases.
Funding snapshot
- Total raised
- $428MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $350M2024-03-01
Funding rounds
- Round, 2024
- $350M2024-03-01, SEC form D sold, 36 investors
- Round, 2018
- $60M2018-02-09, SEC form D sold, 12 investors
- Round, 2015
- $18M2015-10-30, SEC form D sold, 8 investors
About the company
- Status notes
- Vertex to Acquire Crinetics Pharmaceuticals
Exit
- Acquisition
- 2026-07-06
Loading relationship preview